Skip to main content
showDesktop,showTablet,showMobile

Thymus Cancer Stages

After someone is diagnosed with thymus cancer, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes the extent of the cancer in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.

Thymus cancer ranges from stages I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread beyond the thymus to the lymph nodes or to other organs. And within a stage, an earlier letter means a lower stage.

Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.

How is the cancer stage determined?

The staging system used for thymus cancer is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:

  • The extent (size) of the main primary tumor (T): Has the cancer grown into nearby structures and if so, how far has it grown?
  • The spread to nearby lymph nodes (N): Has the cancer spread to nearby lymph nodes?
  • The spread (metastasis) to distant parts of the body (M): Has the cancer spread to the outer linings of the lungs or heart or to distant organs?

The staging system described below is the most recent AJCC system. This system is used to stage thymomas, thymic carcinomas and thymic neuroendocrine tumors .

Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced. Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage. For more information see Cancer Staging.

The staging system in the table below uses the pathologic stage (also called the surgical stage). It is determined by examining tissue removed during an operation. Sometimes, if surgery is not possible right away or at all, the cancer will be given a clinical stage instead. This is based on the results of a physical exam, biopsy, and imaging tests (CT or MRI scan, x-rays, PET scan, etc) done before surgery.

Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand.

AJCC Stage

Stage grouping

Stage description*

I

 

T1a

N0

M0

The tumor has not spread into the outer layer of the thymus OR it has grown into the nearby fatty tissues but not into the mediastinal pleura (the thin layer covering the space between the lungs) (T1a). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

OR

T1b

N0

M0

The tumor has grown into the nearby fatty tissue and the mediastinal pleura (the thin layer covering the space between the lungs) (T1b). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

II

T2

N0

M0

The tumor has grown into the nearby fatty tissue and into the pericardium (the tissue sac containing the heart) (T2).

The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

IIIA

 

T3

N0

M0

The tumor is growing into nearby tissues or organs, including the lungs, the vessels carrying blood into or out of the lungs, the main blood vessels taking blood away from the heart (the superior vena cava), or the phrenic nerve (the nerve that controls the diaphragm and breathing) (T3). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

IIIB

 

T4

N0

M0

The tumor is growing into nearby tissues or organs, including the trachea (windpipe), esophagus (feeding tube), or the main blood vessels pumping blood away from the heart (T4). The cancer has not spread to nearby lymph nodes (N0) or to distant parts of the body (M0).

 

IVA

Any T

N1

M0

 

The tumor might or might not have grown into nearby tissues or organs (Any T) AND the cancer has spread to nearby lymph nodes in the front chest cavity (N1). It has not spread to distant parts of the body (M0).

OR

Any T

N0 or N1

M1a

The tumor might or might not have grown into nearby tissues or organs (Any T) and the cancer might or might not have spread to nearby lymph nodes (N0 or N1). The cancer has spread to the pleura (lining of the lung) or the pericardium (lining of the heart) (M1a).

 

IVB

Any T

N2

M0 or M1a

The tumor might or might not have grown into nearby tissues or organs (Any T) AND the cancer has spread to the lymph nodes deep in the chest or the neck (N2). It might or might not have spread to the pleura (lining of the lung) or the pericardium (lining of the heart) (M0 or M1b).

OR

Any T

Any N

M1b

The tumor might or might not have grown into nearby tissues or organs (Any T). The cancer might or might not have spread to nearby lymph nodes in the chest cavity or neck (Any N), but it has spread to the inside of the lungs or other distant organs (M1b).

 

* The following additional categories are not listed in the table above:

  • TX: Main tumor cannot be assessed due to lack of information.
  • T0: No evidence of a primary tumor.
  • NX: Regional lymph nodes cannot be assessed due to lack of information. 

Other prognostic factors

A person’s prognosis (outlook) after treatment of a thymus cancer depends largely on its stage.  But other features are also important such as the type of thymus cancer (as described in What Is Thymus Cancer?) and if surgery can remove the entire tumor.

side by side logos for American Cancer Society and American Society of Clinical Oncology

Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).

 

American Joint Committee on Cancer. Thymus. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 423-429.

Kaidar-Person O, Zagar T, Haithcock BE, Weiss J. Chapter 70: Diseases of the Pleura and Mediastinum. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2019.

Meneshian A, Oliver KR, Molina JR. Clinical presentation and management of thymoma and thymic carcinoma. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/clinical-presentation-and-management-of-thymoma-and-thymic-carcinoma on October 21, 2024.

National Cancer Institute. Thymoma and Thymic Carcinoma Treatment (PDQ®)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq on October 21, 2024.

Last Revised: December 6, 2024

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.